Literature DB >> 6172011

An argyrophil III method for the demonstration of fibrous neuroglia.

F Gallyas.   

Abstract

The catalytic activity of the fibrous astrocytes in the reaction of silver ions with dissolved reducing molecules is considerably increased by ethylation and a subsequent treatment with NaJO3. As a consequence, in a special physical developer they produce metallic silver at a considerably higher rate than do other tissue elements, making possible their selective demonstration. In freshly fixed materials myelin too is silverized. This can be avoided by means of pretreatments with performic acid and iodine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6172011

Source DB:  PubMed          Journal:  Acta Morphol Acad Sci Hung        ISSN: 0001-6217


  8 in total

1.  Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington's disease.

Authors:  H Heinsen; U Rüb; D Gangnus; G Jungkunz; M Bauer; G Ulmar; B Bethke; M Schüler; F Böcker; W Eisenmenger; M Götz; M Strik
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

2.  Physico-chemical mechanism of the argyrophil III reaction.

Authors:  F Gallyas
Journal:  Histochemistry       Date:  1982

3.  Pathoarchitectonics of the cerebral cortex in chorea-acanthocytosis and Huntington's disease.

Authors:  J Liu; H Heinsen; L T Grinberg; E Alho; E Amaro; C A Pasqualucci; U Rüb; K Seidel; W den Dunnen; T Arzberger; C Schmitz; M C Kiessling; B Bader; A Danek
Journal:  Neuropathol Appl Neurobiol       Date:  2018-06-10       Impact factor: 8.090

4.  Cortical and striatal neurone number in Huntington's disease.

Authors:  H Heinsen; M Strik; M Bauer; K Luther; G Ulmar; D Gangnus; G Jungkunz; W Eisenmenger; M Götz
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Immunohistochemical localization of extravasated serum albumin in the hippocampus of human subjects with partial and generalized epilepsies and epileptiform convulsions.

Authors:  A Mihály; B Bozóky
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

6.  Unsuspected (clinically silent) multiple sclerosis. Quantitative investigations in one autoptic case.

Authors:  H Heinsen; U Lockemann; K Püschel
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

7.  Impaired hepatic amyloid-beta degradation in Alzheimer's disease.

Authors:  Chera L Maarouf; Jessica E Walker; Lucia I Sue; Brittany N Dugger; Thomas G Beach; Geidy E Serrano
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

8.  Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition.

Authors:  Jessica R Filon; Anthony J Intorcia; Lucia I Sue; Elsa Vazquez Arreola; Jeffrey Wilson; Kathryn J Davis; Marwan N Sabbagh; Christine M Belden; Richard J Caselli; Charles H Adler; Bryan K Woodruff; Steven Z Rapscak; Geoffrey L Ahern; Anna D Burke; Sandra Jacobson; Holly A Shill; Erika Driver-Dunckley; Kewei Chen; Eric M Reiman; Thomas G Beach; Geidy E Serrano
Journal:  J Neuropathol Exp Neurol       Date:  2016-06-12       Impact factor: 3.685

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.